Boucher R - Search Results

1

Effect of ethosuximide on rest tremor in the MPTP monkey model.

Gomez-Mancilla B, Latulippe JF, Boucher R, Bédard PJ. Gomez-Mancilla B, et al. Among authors: boucher r. Mov Disord. 1992;7(2):137-41. doi: 10.1002/mds.870070207. Mov Disord. 1992. PMID: 1350061

2

Effect of D1 receptor stimulation in normal and MPTP monkeys.

Bédard PJ, Boucher R. Bédard PJ, et al. Among authors: boucher r. Neurosci Lett. 1989 Sep 25;104(1-2):223-8. doi: 10.1016/0304-3940(89)90358-3. Neurosci Lett. 1989. PMID: 2573015

3

Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.

Falardeau P, Bouchard S, Bédard PJ, Boucher R, Di Paolo T. Falardeau P, et al. Among authors: boucher r. Eur J Pharmacol. 1988 May 20;150(1-2):59-66. doi: 10.1016/0014-2999(88)90750-9. Eur J Pharmacol. 1988. PMID: 3261249

4

Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkeys.

Blanchet PJ, Boucher R, Bédard PJ. Blanchet PJ, et al. Among authors: boucher r. Brain Res. 1994 Jul 4;650(1):32-9. doi: 10.1016/0006-8993(94)90203-8. Brain Res. 1994. PMID: 7953674

5

Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.

Gomez-Mancilla B, Boucher R, Gagnon C, Di Paolo T, Markstein R, Bédard PJ. Gomez-Mancilla B, et al. Among authors: boucher r. Mov Disord. 1993 Apr;8(2):144-50. doi: 10.1002/mds.870080205. Mov Disord. 1993. PMID: 8474480

6

Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.

Gomez-Mancilla B, Boucher R, Bédard PJ. Gomez-Mancilla B, et al. Among authors: boucher r. Mov Disord. 1992;7(1):43-7. doi: 10.1002/mds.870070108. Mov Disord. 1992. PMID: 1348351

7

Effect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism.

Gomez-Mancilla B, Boucher R, Bédard PJ. Gomez-Mancilla B, et al. Among authors: boucher r. Clin Neuropharmacol. 1991 Aug;14(4):359-66. doi: 10.1097/00002826-199108000-00008. Clin Neuropharmacol. 1991. PMID: 1913702

8

[Animal models of tardive dyskinesia].

Bédard PJ, Boucher R, DiPaolo T. Bédard PJ, et al. Among authors: boucher r. Encephale. 1988 Sep;14 Spec No:163-6. Encephale. 1988. PMID: 2905644 Review. French.

9

Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys.

Di Paolo T, Bédard P, Daigle M, Boucher R. Di Paolo T, et al. Among authors: boucher r. Brain Res. 1986 Aug 6;379(2):286-93. doi: 10.1016/0006-8993(86)90782-1. Brain Res. 1986. PMID: 2427166

10

Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding.

Bédard PJ, Di Paolo T, Falardeau P, Boucher R. Bédard PJ, et al. Among authors: boucher r. Brain Res. 1986 Aug 6;379(2):294-9. doi: 10.1016/0006-8993(86)90783-3. Brain Res. 1986. PMID: 3488796

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

932 results

Search Page

Filters